Last edition
News about Industrial talks
India’s pharmaceutical export industry is preparing for 2026 with a sharp focus on quality excellence, regulatory compliance and diversification into new global markets, according to the Pharmaceuticals Export Promotion Council of India (Pharmexcil).
Industrial talks | 02/01/2026 | By Darshana | 326
Valneva and Serum Institute End Chikungunya Vaccine Licensing Deal
Valneva SE and the Serum Institute of India have mutually agreed to discontinue their licensing agreement for Valneva’s single-shot chikungunya vaccine, bringing the collaboration to a close by mutual consent.
Industrial talks | 01/01/2026 | By News Bureau | 112
Cogent Biosciences Submits NDA for Bezuclastinib in Non Advanced Systemic Mastocytosis
Cogent Biosciences has submitted a New Drug Application to the US FDA for bezuclastinib in non-advanced systemic mastocytosis, supported by positive results from the SUMMIT pivotal trial and following its Breakthrough Therapy Designation for patients with smouldering systemic mastocytosis and previously treated NonAdvSM.
Industrial talks | 31/12/2025 | By News Bureau | 196
Evogene Appoints Dr Olga Nissan as VP for Business Development
Evogene has appointed Dr Olga Nissan as Vice President of Business Development, effective 1 January, 2026, bringing to the role a seasoned biotechnology and pharmaceutical leader with extensive experience spanning R&D, clinical development and business operations across pharma, diagnostics and agri-biotechnology sectors.
Industrial talks | 31/12/2025 | By News Bureau
Akums Signs MoU with Sharda University Agra to Advance Pharma Research
Akums Drugs & Pharmaceuticals has entered into a Memorandum of Understanding (MoU) with Sharda University, Agra, to collaborate on pharmaceutical research, technology transfer, and skill development, with an emphasis on strengthening the linkage between academic research and industrial application.
Industrial talks | 29/12/2025 | By Darshana | 123
WHO and AYUSH Ministry Hold Technical Meet on Integrating AYUSH into Global Health Standards
WHO and Ministry of AYUSH held a technical meeting to advance the integration of Ayurveda, Siddha and Unani (ASU) systems into global health standards, laying the groundwork for a Traditional Medicine (TM) module within the International Classification of Health Interventions (ICHI), with India supporting the required financial and technical frameworks.
Industrial talks | 22/12/2025 | By News Bureau | 135
WHO Hosts 2nd Global Summit to Promote Innovation and Integration in Traditional Medicine
The World Health Organization’s second Global Summit on Traditional Medicine has convened global leaders, scientists and indigenous practitioners from over 100 countries, with key scientific initiatives and new commitments expected to advance the WHO Global Traditional Medicine Strategy 2025–2034.
Industrial talks | 19/12/2025 | By News Bureau | 179
Lupin's Climate Targets Across All Emission Scopes Validated by SBTi
Global pharmaceutical major Lupin Limited has announced that its greenhouse gas emissions reduction targets have been officially validated by the Science Based Targets initiative. The validation covers Scope 1, Scope 2 and Scope 3 emissions, aligning Lupin’s climate strategy with the Paris Agreement goal of limiting global temperature rise to 1.5°C.
Industrial talks | 16/12/2025 | By Darshana | 133
Indoco Receives USFDA EIR for Patalganga API Manufacturing Facility
Indoco has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration for its API manufacturing facility at Patalganga following an inspection conducted in the month of September.
Industrial talks | 15/12/2025 | By News Bureau | 139
Jubilant Pharmova Appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics
Jubilant Pharmova has announced the appointment of Daniel J. O’Connor as CEO of its proprietary novel drugs business, Jubilant Therapeutics Inc.
Industrial talks | 02/12/2025 | By Dineshwori | 207
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy